TY  - GEN
AU  - Majumder,Mousumi
AU  - Xin,Xiping
AU  - Liu,Ling
AU  - Girish,Gannareddy V
AU  - Lala,Peeyush K
TI  - Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions
SN  - 1349-7006
PY  - 2014///1117
KW  - Adenocarcinoma
KW  - blood supply
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - Benzamides
KW  - Celecoxib
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cyclooxygenase 2
KW  - metabolism
KW  - Drug Screening Assays, Antitumor
KW  - Female
KW  - Lung Neoplasms
KW  - Lymphangiogenesis
KW  - Lymphatic Metastasis
KW  - Macrophages
KW  - Mammary Neoplasms, Experimental
KW  - Mice
KW  - Mice, Inbred C3H
KW  - Molecular Targeted Therapy
KW  - Neoplasm Transplantation
KW  - Neoplastic Stem Cells
KW  - Neovascularization, Pathologic
KW  - drug therapy
KW  - Pyrazoles
KW  - Receptors, Prostaglandin E, EP4 Subtype
KW  - antagonists & inhibitors
KW  - Sulfonamides
KW  - Tumor Burden
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/cas.12475
ER  -